Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05868421 · ClinicalTrials.gov registry record · NA

Veteran Social Support for Enhancing Use of Smoking Cessation Treatment

A NA study of Smoking Cessation and Veterans Health, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
2,376
Enrollment target
1
Study location

NCT05868421: Recruiting NA study of Smoking Cessation and Veterans Health, sponsored by VA Office of Research and Development.

NCT05868421 is a NA study of Smoking Cessation and Veterans Health that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 2,376 participants, above the 462-participant average among 188 other Smoking Cessation trials with a reported enrollment target (414% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05868421, a NA study of Smoking Cessation and Veterans Health, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
2,376 participants
Enrollment target
1
Study location

Study Summary

This study is recruiting Veterans who currently smoke cigarettes and support persons who are nominated by the Veterans. The purpose of this study is to assist Veterans with smoking cessation by asking Veterans to choose a support person who will assist them with the quitting process, or who may assist them with the quitting process once the Veteran is ready to quit smoking sometime in the future. Study staff will assess how much or how little social support during the Veteran's quitting process is helpful to the Veteran. This information will help us come up with new ways to help Veterans quit smoking that are better tailored to their needs.

Primary Outcome

The primary outcome will be use of any EBCT assessed at the 6 month follow-up: medication, behavioral intervention, or combination using both self-report and VHA administrative data. Data will be extracted from the VA Corporate Data Warehouse (CDW) to assess VA treatment use. VA outpatient prescription records will be used to assess receipt and amount of pharmacotherapy (bupropion, varenicline, nicotine replacement therapy (NRT)) and VA outpatient encounters associated with smoking cessation wil

Interventions

  • BEHAVIORAL Support Person Coaching Call
  • BEHAVIORAL SP written materials
  • BEHAVIORAL Written Smoking Cessation Materials

Study Locations (1)

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis

Trial Details

FieldValue
Enrollment Target 2,376 participants
Start Date 2024-02-01
Est. Completion 2028-02-01
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05868421 shows while recruiting

NCT05868421 is an interventional study that assigns participants to a tested intervention. Its 2,376 participants enrollment target places it among the larger protocols in the corpus, above the 462-participant average among 188 other Smoking Cessation trials with a reported enrollment target (414% higher).

The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which Support Person Coaching Call is the first listed.

NCT05868421 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05868421 about?

NCT05868421 is a clinical study titled "Veteran Social Support for Enhancing Use of Smoking Cessation Treatment". This study is recruiting Veterans who currently smoke cigarettes and support persons who are nominated by the Veterans. The purpose of this study is to assist Veterans with smoking cessation by asking Veterans to choose a support person who will assist them with the quitting process, or who may assi...

What is the current status of trial NCT05868421?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,376 participants. The study started on 2024-02-01. Estimated completion is 2028-02-01.

What conditions does trial NCT05868421 study?

This clinical trial studies the following conditions: Smoking Cessation, Veterans Health.

What interventions are being tested in trial NCT05868421?

The interventions under investigation include: Support Person Coaching Call (BEHAVIORAL), SP written materials (BEHAVIORAL), Written Smoking Cessation Materials (BEHAVIORAL).

Who is sponsoring clinical trial NCT05868421?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05868421 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05868421's enrollment target sits among peer trials

2,376 6th of 188 higher than 183 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06747494 · 2,396 participants · NA

    General vs Spinal in Total Joint Arthroplasty (TJA)

  • NCT05185440 · 2,400 participants · NA

    Reducing Alcohol Involved Sexual Violence in Higher Education

  • NCT05285527 · 2,400 participants · NA

    MiSight 1 Day Safety Post-Approval Study

  • NCT05738330 · 2,400 participants · NA

    Symptom Monitoring in Hemodialysis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05868421, the US trial registry maintained by the National Library of Medicine. NCT05868421 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.